BSECompany Update6h ago · 22 Jul 2026, 01:18 pm
Please find enclosed herewith the Newspaper publication regarding Notice to Shareholders for Transfer of Unclaimed Final Dividend 2018-2019 and its corresponding Equity Shares to IEPF.
Bliss GVS Pharma Ltd · 506197
✦ AI SummaryRegulatory
Bliss GVS Pharma Ltd has published a notice in newspapers regarding the transfer of unclaimed final dividend 2018-2019 and its corresponding equity shares to the Investor Education and Protection Fund (IEPF) Authority, as per the Companies Act, 2013 and the Investor Education and Protection Fund Authority (Accounting, Audit, Transfer and Refund) Rules, 2016.
Analysis Scores
Earnings Impact1/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk6/10
Balance Sheet Risk1/10
Liquidity Impact1/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Bliss GVS Pharma Ltd - 506197 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Attachments (1)
📄pdf
Download →
5104ebc3-633e-4c4e-9364-4206c334a0e1.pdf
View document text
July 22, 2026
To To
The Manager, Listing Department The General Manager, Listing Department
National Stock Exchange of India Limited BSE Limited
Plot no. C/1 G Block, Phiroze Jeejeebhoy Towers,
Bandra-Kurla Complex, Bandra (East), Dalal Street,
Mumbai- 400 051 Mumbai- 400 001
Symbol: BLISSGVS Scrip Code: 506197
Dear Sir/Madam,
Subject: Newspaper Advertisement- Publication of Notice to Shareholders for Transfer of
Unclaimed Final Dividend 2018-2019 and its corresponding Equity Shares to Investor
Education and Protection Fund (IEPF) Authority
In accordance with Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015, we hereby enclose copies of the newspaper advertisement of the notice
published in The Free Press Journal (English), Economic Times (English), Maharashtra Times and
Navshakti (Regional) on July 21, 2026, concerning the proposed transfer of unclaimed final
dividend 2018-2019 and its corresponding shares to IEPF Authority, pursuant to Section 124(6) of
the Companies Act, 2013 read with the Investor Education and Protection Fund Authority
(Accounting, Audit, Transfer and Refund) Rules, 2016, as amended from time to time.
The aforesaid advertisement is also available on the website of the Company at
https://www.blissgvs.com/
You are requested to take the above on record.
Yours faithfully,
For Bliss GVS Pharma Limited
Aditi Bhatt
Company Secretary
Encl: a/a